Lilly sues 6 companies over alleged retatrutide sales
Eli Lilly has filed six lawsuits against U.S. entities it accuses of illegally selling versions of its experimental obesity drug retatrutide. The lawsuits target compounding pharmacies, medical spas and online sellers that allegedly sold retatrutide products, according to an Aug. 12 news release. Retatrutide is an investigational molecule in phase 3 clinical trials for obesity, […] The post Lilly sues 6 companies over alleged retatrutide sales appeared first on Becker's Hospital Revie...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.